Kolinpharma SpA
MIL:KIP

Watchlist Manager
Kolinpharma SpA Logo
Kolinpharma SpA
MIL:KIP
Watchlist
Price: 9.9 EUR Market Closed
Market Cap: €16.2m

Kolinpharma SpA
Investor Relations

Kolinpharma SpA engages in the research, development, and marketing of food supplements based on natural raw materials of natural origin. The company is headquartered in Lainate, Milano and currently employs 110 full-time employees. The company went IPO on 2018-03-09. The firm offers a number of products, including almetax, which is a food supplement based on alpha-lipoic acid, L-tryptophan, turmeric, vitamins B5, b6 AND C, Chromium picolinade and Zinc that acts synergistically on the main symptoms of menopause; Almatex easy, which enables the preservation of the general well-being of the body; Dolasix, which is a food supplement that acts synergistically in favor of the normal functionality of cartilages and connective tissues; Ivuxur, which is a food supplement based on cranberry ( dried cranberry extract), D-mannose, bearberry and Zinc that is used in the treatment of unary tract infections; Milesax, which is a food supplement based on magnesium bisglycinate, boswellia serrata and L-tryptophan that acts synergistically on contractures, muscles relaxation and mood during the rehabilitation and recovery phases, and Xinepa, among others.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Ms. Rita Paola Petrelli
Co-Founder, CEO, Chairwoman of The Board & CFO
No Bio Available
Mr. Massimo Mantella
CEO & Director
No Bio Available
Dr. Anna Lambiase
Investor Relations
No Bio Available

Contacts

Address
MILANO
Lainate
Corso Europa, 5
Contacts
+390294324300
www.kolinpharma.com